沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

09996 沛嘉医疗-B

休市中 06-12 16:08:21

4.180

+0.040

+0.97%

最高4.210	最低4.030	成交量119.70万
今开4.140	昨收4.140	日振幅4.35%
总市值28.22亿	流通市值28.22亿	总股本6.75亿
成交额495.49万	换手率0.18%	流通股本6.75亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"09996","market":"HK","secType":"STK","nameCN":"沛嘉医疗-B","latestPrice":4.18,"timestamp":1781251701009,"preClose":4.14,"halted":0,"volume":1197002,"delay":0,"changeRate":0.00966183574879228,"floatShares":675000000,"shares":675000000,"eps":-0.3540338071181739,"marketStatus":"休市中","change":0.04,"latestTime":"06-12 16:08:21","open":4.14,"high":4.21,"low":4.03,"amount":4954931,"amplitude":0.043478,"askPrice":4.18,"askSize":5000,"bidPrice":4.13,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.3540338071181739,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1781487000000},"marketStatusCode":7,"adr":0,"listingDate":1589472000000,"exchange":"SEHK","adjPreClose":4.14,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":0.909431,"lotSize":1000,"spreadScale":0,"tradeCurrency":"HKD"},"requestUrl":"/m/hq/s/09996/tweets","defaultTab":"tweets","newsList":[{"id":"2642264164","title":"中恒集团最新公告：控股孙公司获两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2642264164","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642264164?lang=zh_cn&edition=full","pubTime":"2026-06-12 18:09","pubTimestamp":1781258984,"startTime":"0","endTime":"0","summary":"中恒集团(600252.SH)公告称，公司控股孙公司海南莱美医疗器械有限公司收到海南省药品监督管理局颁发的麻醉视频喉镜及一次性使用喉镜片两项《医疗器械注册证》，有效期至2031年6月2日。该产品用于指引医护人员准确进行气道插管，有助于丰富公司医疗器械产品种类，提升综合竞争力，但实际销售情况取决于市场推广效果，对业绩影响尚不确定。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026061200028766.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","09996","BK0015","BK0239","159883","BK0028","BK1574","BK1583","BK1100","BK0188","BK0012","600252"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642263510","title":"莱美药业(300006.SZ)子公司获得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2642263510","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642263510?lang=zh_cn&edition=full","pubTime":"2026-06-12 15:59","pubTimestamp":1781251185,"startTime":"0","endTime":"0","summary":"智通财经APP讯，莱美药业(300006.SZ)发布公告，近日，公司控股子公司海南莱美医疗器械有限公司(以下简称“莱美医疗器械”)收到海南省药品监督管理局颁发的两项《医疗器械注册证》，涉及产品：“麻醉视频喉镜”、“一次性使用喉镜片”。本次公司控股子公司获证的麻醉视频喉镜及一次性使用喉镜片，是莱美医疗器械研发的内窥镜产品，该产品能指引医护人员准确进行气道插管，有利于临床使用对患者病症的判断及治疗。此次公司控股子公司产品获证将进一步丰富公司医疗器械产品种类，满足市场多样化的需求，提升公司综合竞争力，对未来经营将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453655.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","300006","BK1100","BK1574","BK0070","09996","BK1583","159883"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642402985","title":"亚太药业(002370.SZ)拟设立子公司 重点探索光动力创新类药物及配套医疗器械的开发","url":"https://stock-news.laohu8.com/highlight/detail?id=2642402985","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642402985?lang=zh_cn&edition=full","pubTime":"2026-06-11 15:50","pubTimestamp":1781164230,"startTime":"0","endTime":"0","summary":"智通财经APP讯，亚太药业 发布公告，根据发展战略和经营规划需要，为进一步完善公司产业发展布局，全资子公司雅泰利众拟以自有资金2000万元设立子公司浙江盛曜光研药业有限公司(暂定名)。光动力是一种利用光敏剂、特定波长光源与氧分子反应破坏病变组织的医疗技术，广泛应用于肿瘤治疗、皮肤病及部分炎症性疾病，是当下医药健康行业的前沿赛道。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1453089.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","BK1583","09996","BK0132","002370","159883","BK1100","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642150468","title":"华东医药(000963.SZ)：注射用聚己内酯微球面部填充剂医疗器械注册申请获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2642150468","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642150468?lang=zh_cn&edition=full","pubTime":"2026-06-09 16:15","pubTimestamp":1780992909,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 华东医药 发布公告，2026年6月8日，公司全资子公司欣可丽美学(杭州)供应链管理有限公司收到国家药品监督管理局签发的《受理通知书》，其代理申报的三类医疗器械注射用聚己内酯微球面部填充剂Ellansé伊妍仕S型拓展新适用症的变更注册申请获得受理，本次申请新增适用症：用于额部皮下或骨膜上植入，以改善中至重度额部轮廓缺陷。公司后续将继续全力开展这款产品在中国的注册工作，推动其新适用症早日获批。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451935.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","000963","09996","BK0209","BK1574","BK0196","LU2328871848.SGD","LU1969619763.USD","BK0175","159883","BK1100","BK0187","BK0132","BK0183","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642545453","title":"国金证券：聚焦医疗器械“创新+出海”双主线 建议重点关注2026年业绩有望加速细分龙头","url":"https://stock-news.laohu8.com/highlight/detail?id=2642545453","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2642545453?lang=zh_cn&edition=full","pubTime":"2026-06-09 09:15","pubTimestamp":1780967709,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国金证券发布研报称，聚焦医疗器械“创新+出海”双主线。当前医疗器械板块正迎来“基本面复苏”与“估值体系重构”的双击机遇。建议重点关注2026年业绩有望加速的细分龙头。国金证券主要观点如下：医疗器械板块当前投资应紧扣出海及创新双主线出海不仅帮助优质企业突破国内增长天花板，还能利用海外高定价市场提升盈利质量;而具备临床差异化价值的创新产品，则是抵御国内价格压力的核心护城河。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451765.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0276","BK1583","BK0188","BK1574","BK0028","BK0183","600109","09996","BK1100","BK0201","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641044461","title":"九强生物(300406.SZ)：两款产品取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2641044461","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641044461?lang=zh_cn&edition=full","pubTime":"2026-06-08 15:52","pubTimestamp":1780905120,"startTime":"0","endTime":"0","summary":"智通财经APP讯， 九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的《医疗器械注册证》，涉及产品：“可溶性生长刺激表达基因2蛋白测定试剂盒(胶乳免疫比浊法)”、“全自动凝血分析仪(型号：MDC3600、 MDC2600)”。上述产品医疗器械注册证的取得，丰富了公司在体外诊断生化和凝血分析仪器细分领域产品线的品种，有利于进一步提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451339.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK0239","300406","BK1100","BK0077","BK1574","BK0028","BK0046","BK0012","BK1583","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641665106","title":"香港医管局：香港引进药械办已投入运作 料将优化新药械及好药械引进程序","url":"https://stock-news.laohu8.com/highlight/detail?id=2641665106","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641665106?lang=zh_cn&edition=full","pubTime":"2026-06-08 13:46","pubTimestamp":1780897598,"startTime":"0","endTime":"0","summary":"引进药械办已于今日投入运作，将会大大加快引入“新药”及“好药”的程序，尽快纳入医管局药物名册，有效全面提升病人获得更佳治疗的机会。香港医管局表示，有信心引进药械办投入运作后，会大大优化引进创新药物及医疗器械的流程，令更多创新药物及医疗器械更快引入到公立医院供病人使用，提升治疗成效及病人福祉。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1451280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1100","BK1583","09996","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641116639","title":"山外山最新公告：全资子公司取得血液透析干粉医疗器械变更注册文件","url":"https://stock-news.laohu8.com/highlight/detail?id=2641116639","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2641116639?lang=zh_cn&edition=full","pubTime":"2026-06-05 16:45","pubTimestamp":1780649148,"startTime":"0","endTime":"0","summary":"山外山(688410.SH)公告称，公司全资子公司重庆天外天生物技术有限公司近日收到国家药监局颁发的医疗器械变更注册文件，产品为血液透析干粉，主要变更内容为产品技术要求。本次变更为常规合规性技术升级，不涉及核心配方及适用范围调整，有利于增强公司产品综合竞争力。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060500028479.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK1574","BK1100","159883","09996","BK1583","688410"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640599581","title":"乐心医疗最新公告：医疗器械注册证变更获受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2640599581","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640599581?lang=zh_cn&edition=full","pubTime":"2026-06-04 18:10","pubTimestamp":1780567824,"startTime":"0","endTime":"0","summary":"乐心医疗(300562.SZ)公告称，公司近日收到广东省药品监督管理局通知，申报的腕式电子血压计医疗器械注册证变更事项已获受理。本次变更新增产品型号BWZ51、BWZ52，旨在满足市场需求、扩大业务范围。该事项尚处受理阶段，后续需进一步核准认证，存在不确定性。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060400032114.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","159883","BK1574","BK1583","BK0114","BK0109","300562","BK1100","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640153266","title":"九强生物(300406.SZ)：全自动化学发光免疫分析仪取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640153266","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640153266?lang=zh_cn&edition=full","pubTime":"2026-06-04 16:37","pubTimestamp":1780562251,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的全自动化学发光免疫分析仪(型号Gi3000)《医疗器械注册证》。该产品医疗器械注册证的取得，丰富了公司在体外诊断化学发光细分领域产品线的品种，有利于进一步提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450116.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300406","BK0046","BK0077","BK0012","BK1583","BK1574","BK1100","BK0028","BK0239","159883","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640158880","title":"港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640158880","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640158880?lang=zh_cn&edition=full","pubTime":"2026-06-04 15:54","pubTimestamp":1780559657,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，昊海生科尾盘涨近3%，截至发稿，涨2.87%，报17.87港元，成交额411.34万港元。消息面上，昊海生科公告称，其控股子公司赛美视自主研发的三焦点人工晶状体获得国家药品监督管理局的注册批准。该人工晶状体用于植入囊袋内。该产品是公司本年度获批的又一款多焦点人工晶状体产品，不仅加速并完善了公司在高端多焦点人工晶状体领域的布局，更为眼科业务的发展注入了新动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06826","BK1161","BK1593","VXUS","BK4588","BK4585","159883","BK0239","688366","09996","BK0251","BK1100","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640136062","title":"河北省衡水市冀州区开展医疗器械生产企业专项检查","url":"https://stock-news.laohu8.com/highlight/detail?id=2640136062","media":"中国质量新闻网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640136062?lang=zh_cn&edition=full","pubTime":"2026-06-04 10:55","pubTimestamp":1780541700,"startTime":"0","endTime":"0","summary":"中国质量新闻网讯 为压实医疗器械生产企业质量安全主体责任，规范生产经营行为，防范化解质量安全风险，近日，河北省衡水市冀州区市场监督管理局开展医疗器械生产企业专项检查，全力守护辖区医疗器械质量安全。下一步，冀州区市场监督管理局将紧盯医疗器械监管薄弱环节，健全常态化巡查、不定期抽查监管机制，持续加大监管执法力度，严厉打击各类医疗器械生产违法违规行为，持续规范行业生产秩序，守护群众用械安全。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-06-04/doc-iniaffcu3766626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["159883","BK1100","09996","BK1583","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640742906","title":"惠泰医疗(688617.SH)子公司取得两项医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640742906","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640742906?lang=zh_cn&edition=full","pubTime":"2026-06-03 19:02","pubTimestamp":1780484555,"startTime":"0","endTime":"0","summary":"智通财经APP讯，惠泰医疗(688617.SH)发布公告，近日，公司控股子公司深圳皓影医疗科技有限公司取得两项医疗器械注册证，产品分别为血管内超声诊断设备与一次性使用血管内超声诊断导管。上述医疗器械注册证的取得，有利于丰富公司的产品种类，扩充公司在冠脉介入影像领域的产品布局，不断满足多元化的临床需求，进一步增强公司的核心竞争能力。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449727.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1583","159883","688617","BK1574","09996","BK1100","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640974736","title":"九强生物(300406.SZ)：甲状腺素结合力测定试剂盒取得医疗器械注册证书","url":"https://stock-news.laohu8.com/highlight/detail?id=2640974736","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640974736?lang=zh_cn&edition=full","pubTime":"2026-06-03 15:49","pubTimestamp":1780472947,"startTime":"0","endTime":"0","summary":"智通财经APP讯，九强生物(300406.SZ)发布公告，公司于近日收到北京市药品监督管理局颁发的甲状腺素结合力测定试剂盒(磁微粒化学发光免疫分析法)《医疗器械注册证》，该试剂盒用于体外定量测定人血清或血浆中甲状腺素结合力(T-Uptake)。此次医疗器械注册证的取得，丰富了公司在体外诊断化学发光细分领域产品线的品种，有利于进一步提升公司的核心竞争力和市场拓展能力，对公司未来的经营将产生积极影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449565.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","BK0077","BK1574","09996","159883","BK0046","BK0012","BK1583","BK1100","BK0239","300406"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640591084","title":"昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640591084","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640591084?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:35","pubTimestamp":1780400126,"startTime":"0","endTime":"0","summary":"智通财经APP讯，昊海生科 发布公告，公司控股子公司河南赛美视生物科技有限公司于近日收到国家药品监督管理局颁发的关于三焦点人工晶状体产品的《中华人民共和国医疗器械注册证》。该人工晶状体用于植入囊袋内。该产品是公司本年度获批的又一款多焦点人工晶状体产品，不仅加速并完善了公司在高端多焦点人工晶状体领域的布局，更为眼科业务的发展注入了新动能。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1574","09996","BK1100","BK1583","BK0251","159883","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164884314","title":"沛嘉医疗-B5月股份变动月报表，已发行股本增至674,736,912股","url":"https://stock-news.laohu8.com/highlight/detail?id=1164884314","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164884314?lang=zh_cn&edition=full","pubTime":"2026-06-02 18:22","pubTimestamp":1780395727,"startTime":"0","endTime":"0","summary":"沛嘉医疗-B于2026年6月2日披露2026年5月股份变动月报表。公告显示，截至2026年5月31日，公司注册股本维持为1,000,000,000股，面值为每股USD 0.0001，总额为USD 100,000。报告期末，公司已发行股份总数为674,736,912股，较上月底增加2,676,253股，本月无库藏股持有或变动。期权激励方面，“购股权计划”在报告期内行使2,676,253股普通股后，期末剩余未行使的期权数量为26,752,667股。“购股权方案”则无新增授出或行使，期末未行使的期权数目保持在4,571,162股。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640990275","title":"利安科技：公司主要产品广泛应用于消费电子、玩具日用品、汽车配件和医疗器械等领域","url":"https://stock-news.laohu8.com/highlight/detail?id=2640990275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640990275?lang=zh_cn&edition=full","pubTime":"2026-06-02 15:07","pubTimestamp":1780384036,"startTime":"0","endTime":"0","summary":"证券之星消息，利安科技(300784)06月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问贵司主要为罗技（Logitech）（LOGI）代工哪些产品？另外，是否考过成为戴尔科技集团（NYSE:DELL）的产业链供应商？谢谢！利安科技回复：感谢您的关注及建议，公司主要产品广泛应用于消费电子、玩具日用品、汽车配件和医疗器械等领域。公司客户主要为国内外知名企业及上市公司，例如罗技集团、海康集团、Make It Real LLC、普瑞均胜、艾康生物等，谢谢。本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060200023054.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159883","BK0220","09996","BK1100","300784","BK1583","159732","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640798629","title":"沛嘉医疗-B(09996)：加奇生物与贝朗医疗订立独家分销协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2640798629","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640798629?lang=zh_cn&edition=full","pubTime":"2026-06-01 06:20","pubTimestamp":1780266032,"startTime":"0","endTime":"0","summary":"智通财经APP讯，沛嘉医疗-B 发布公告，公司附属公司上海加奇生物科技苏州有限公司与贝朗医疗(上海)国际贸易有限公司订立独家分销协议。根据该协议，加奇生物已取得贝朗医疗旗下产品SeQuent Please CIS紫杉醇药物涂层颅内球囊扩张导管在中国大陆地区的独家分销权。与贝朗医疗的合作进一步丰富了集团神经介入产品组合，强化了集团在创新颅内介入解决方案领域的战略布局。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448206.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159891","BK1574","BK1100","BK1583","09996"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639848602","title":"每周股票复盘：东方生物（688298）获多国医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2639848602","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639848602?lang=zh_cn&edition=full","pubTime":"2026-05-31 04:34","pubTimestamp":1780173252,"startTime":"0","endTime":"0","summary":"截至2026年5月29日收盘，东方生物报收于21.4元，较上周的21.98元下跌2.64%。本周，东方生物5月25日盘中最高价报22.23元。本周关注点来自公司公告汇总：东方生物及子公司近期获得多项医疗器械注册证，涉及多个检测项目及多个国家。公司公告汇总浙江东方基因生物制品股份有限公司及全资子公司美国衡健近期获得多项医疗器械注册证，控股子公司北京新兴四寰完成汉坦病毒IgM抗体检测试剂盒续证。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026053100001427.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["09996","BK1100","BK1583","159883","BK0239","BK1574","688298"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639867886","title":"贝康医疗-B(02170)：GEMS取卵液获国家药监局颁发三类医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2639867886","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2639867886?lang=zh_cn&edition=full","pubTime":"2026-05-29 21:21","pubTimestamp":1780060885,"startTime":"0","endTime":"0","summary":"智通财经APP讯，贝康医疗-B 发布公告，本公司Gems系列的取卵液于近日获得国家药品监督管理局颁发的三类医疗器械注册证。取卵液是IVF诊疗第一道核心试剂，为后续受精、卵裂、囊胚发育提供前置保障。本次获批标志着Gems系列试剂逐步完成全品类闭环布局。目前取卵液、胚胎处理液、受精液、卵裂胚培养液、囊胚培养液、胚胎培养液六款产品已全部拿证，覆盖取卵、配子处理、受精、胚胎培养全诊疗链路。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1448041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["159883","BK1100","02170","BK1574","BK1597","BK1583","09996","BK1222"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.peijiamedical.com","stockEarnings":[{"period":"1week","weight":-0.0633},{"period":"1month","weight":-0.2874},{"period":"3month","weight":-0.2737},{"period":"6month","weight":-0.3323},{"period":"1year","weight":-0.3213},{"period":"ytd","weight":-0.3111}],"compareEarnings":[{"period":"1week","weight":-0.0398},{"period":"1month","weight":-0.0797},{"period":"3month","weight":-0.0478},{"period":"6month","weight":-0.0665},{"period":"1year","weight":-0.0048},{"period":"ytd","weight":-0.0539}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"沛嘉医疗有限公司是一家主要提供介入手术医疗器械产品的投资控股公司。该公司主要运营两个业务分部，经导管瓣膜治疗业务分部和神经介入业务分部。经导管瓣膜治疗业务分部主要从事研发、制造及销售经导管瓣膜治疗医疗器械业务。神经介入业务分部主要从事研发、制造及销售神经介入手术医疗器械业务。该公司的产品包括TaurusOne、TaurusElite等商业化产品。该公司主要在中国境内开展业务。","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.057115},{"month":2,"riseRate":0.5,"avgChangeRate":0.017515},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.100991},{"month":4,"riseRate":0.8,"avgChangeRate":0.053778},{"month":5,"riseRate":0.6,"avgChangeRate":-0.096849},{"month":6,"riseRate":0.571429,"avgChangeRate":0.04878},{"month":7,"riseRate":0.5,"avgChangeRate":0.047595},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.086603},{"month":9,"riseRate":0.333333,"avgChangeRate":0.014494},{"month":10,"riseRate":0.5,"avgChangeRate":-0.005393},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.027135},{"month":12,"riseRate":0.666667,"avgChangeRate":0.083675}],"exchange":"SEHK","name":"沛嘉医疗-B","nameEN":"PEIJIA-B"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.43.1","shortVersion":"4.43.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"沛嘉医疗-B,09996,沛嘉医疗-B股票,沛嘉医疗-B股票老虎,沛嘉医疗-B股票老虎国际,沛嘉医疗-B行情,沛嘉医疗-B股票行情,沛嘉医疗-B股价,沛嘉医疗-B股市,沛嘉医疗-B股票价格,沛嘉医疗-B股票交易,沛嘉医疗-B股票购买,沛嘉医疗-B股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"沛嘉医疗-B(09996)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供沛嘉医疗-B(09996)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}